Clinical Trial

Colchicine After Electrocardioversion for Atrial Fibrillation

Study acronym: COLECTRO-AF
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate whether a 3 month treatment course of low-dose Colchicine decreases the recurrence of Atrial fibrillation (AF) after electrocardioversion (ECV) in patients with AF.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-06-05; most recent amendment 2025-05-21.
Status change: Not Yet Recruiting → Recruiting 2024-04-15
Trial Details
NCT Number NCT05890664
Lead Sponsor University Hospital, Basel, Switzerland
Collaborators: Swiss Heart Foundation, Fondation Machaon, Switzerland, Genf, Foundation for Cardiovascular Research Basel
Conditions Atrial Fibrillation, Cardiac Arrhythmia
Enrollment 416 participants
Start Date 2024-04-14
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-05-28